Similar articles

• Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis.

  [No authors listed] [No authors listed] Wkly Epidemiol Rec. 2004 Oct 1;79(40):358-65. Wkly Epidemiol Rec. 2004. PMID: 15631012 English, French. No abstract available.
• Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.

  Fischer PU, King CL, Jacobson JA, Weil GJ. Fischer PU, et al. PLoS Negl Trop Dis. 2017 Jan 5;11(1):e0005163. doi: 10.1371/journal.pntd.0005163. eCollection 2017 Jan. PLoS Negl Trop Dis. 2017. PMID: 28056015 Free PMC article. No abstract available.
• Albendazole for mass drug administration to eliminate lymphatic filariasis.

  Sabesan S. Sabesan S. Lancet Infect Dis. 2006 Nov;6(11):684-5. doi: 10.1016/S1473-3099(06)70608-9. Lancet Infect Dis. 2006. PMID: 17067916 No abstract available.
• Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators.

  Biritwum NK, de Souza DK, Marfo B, Odoom S, Alomatu B, Asiedu O, Yeboah A, Hervie TE, Mensah EO, Yikpotey P, Koroma JB, Molyneux D, Bockarie MJ, Gyapong JO. Biritwum NK, et al. PLoS Negl Trop Dis. 2017 Mar 23;11(3):e0005280. doi: 10.1371/journal.pntd.0005280. eCollection 2017 Mar. PLoS Negl Trop Dis. 2017. PMID: 28333930 Free PMC article. Review. No abstract available.
• Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame.

  Rebollo MP, Bockarie MJ. Rebollo MP, et al. Expert Rev Anti Infect Ther. 2013 Jul;11(7):723-31. doi: 10.1586/14787210.2013.811841. Expert Rev Anti Infect Ther. 2013. PMID: 23879610 Review.